ReviewJournal of clinical medicine2024
The Status of Fertility Preservation (FP) Insurance Mandates and Their Impact on Utilization and Access to Care.
Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 19 citations in OpenAlex.
- Barriers to fertility preservation among cancer patients in the Middle East and North Africa (MENA) region: a scoping review.Discover oncology · 2026Review
- Young adults with primary brain tumors: predictors of referral to a fertility specialist for fertility preservation counseling and the impact on tumor treatment.Journal of neuro-oncology · 2026Article
- Development of medical freezing measures in women during the last decade from 2014 to 2023: registry data of the tri-national network FertiPROTEKT.Archives of gynecology and obstetrics · 2026Article
- Identifying Barriers to Fertility Preservation in Adolescent and Young Adult Cancer Patients.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2026Article
- Article
- Fertility counseling among family physicians in Turkey: a cross-sectional survey of knowledge, attitudes, and practices.Frontiers in medicine · 2026Article
- Access to Fertility Preservation: A Policy Review on State-Level Mandates for Iatrogenic Infertility.The Permanente journal · 2025Article
- Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis.Current oncology (Toronto, Ont.) · 2025Review
- Reproductive health considerations for IDH-mutant glioma patients considering IDH inhibitor therapy: A retrospective cohort study.Neuro-oncology practice · 2025Article
- Interest in Fertility Preservation Among Adults Seen at a Gender Care Clinic.Journal of clinical medicine · 2025Article
- An opportunity for fertility preservation in neurosurgical spinal ependymoma patients: a single center review.Frontiers in reproductive health · 2025Article
- Fertility preservation options at cancer diagnosis; classifying use and decision-making in the United States.Expert review of endocrinology & metabolism · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fertility preservation (FP) is the use of a specific medical intervention to protect the fertility of individuals whose disease or disease treatment may lead to infertility. These medical interventions include the cryopreservation of oocytes, embryos, ovarian tissue, sperm, and testicular tissue; oocyte and embryo cryopreservation are the most widely used interventions in the United States. Although guidelines recommend FP prior to undergoing gonadotoxic treatments, cost barriers are high. For example, the average cost of an oocyte cryopreservation cycle in the United States exceeds $10,000. High cost and lack of insurance coverage are two of the most cited reasons explaining the low Reproductive Endocrinology and Infertility (REI) referral rates and limited FP utilization. Broadening insurance mandates for FP prior to gonadotoxic treatments could improve utilization and provide cancer survivors with improved quality of life post treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.